Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: A 15-year experience

BJU International

Volumn 102, Issue 7, 2008, Pages 844-848

  Cresswell, Joanne ^b   Scheitlin, Walter ^a   Gozen, Ali ^a   Lenz, Elke ^a   Teber, Dogu ^a   Rassweiler, Jens ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adjuvant chemotherapy; Non seminomatous germ cell cancer; Retroperitoneal lymph node dissection; Surveillance

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FOLLOW UP; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; LUNG EMBOLISM; LUNG METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; OPERATION DURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROGRADE EJACULATION; RETROPERITONEAL CANCER; TREATMENT DURATION; TREATMENT OUTCOME; URETER OBSTRUCTION; URETER STENT;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; GERMINOMA; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORCHIECTOMY; PROSPECTIVE STUDIES; RETROPERITONEAL NEOPLASMS; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 50949119926     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07754.x     Document Type: Article

References (18)

1. Choueiri TK, Stephenson AJ, Gilligan T, Klein EA. Management of clinical stage I nonseminomatous germ cell testicular cancer. Urol Clin North Am 2007 34 : 137 48
2. Jewett MAS, Groll RJ. Nerve-sparing retroperitoneal lymphadenectomy. Urol Clin North Am 2007 34 : 149 58
3. Schmoll HJ, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004 15 : 1377 82
4. Albers P, Albrecht W, Algaba F et al., EAU Working Group on Testis Cancer. EAU Guidelines on Testicular Cancer. In EAU Guidelines 2007 : 1 46
5. Albers P, Siener R, Kliesch S et al. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 2003 21 : 1505 12
6. Hao D, Seidel J, Brant R et al. Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol 1998 160 : 768 71
7. Stephenson AJ, Bosl GJ, Motzer RJ et al. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome. J Clin Oncol 2005 23 : 2781 8
8. Nielsen ME, Lima G, Scaeffer EM et al. Oncological efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. 2007 70 : 1168 72
9. Weissbach L, Boedefeld EA. Localisation of solitary and multiple metastases in stage II nonseminomatous testis tumors as a basis for a modified lymph node dissection in stage I. J Urol 1987 138 : 77 82
10. Rassweiler JJ, Seemann O, Henkel TO, Stock C, Frede T, Alken P. Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations. J Urol 1996 156 : 1108 13
11. Rassweiler JJ, Frede T, Lenz E, Seemann O, Alken P. Laparoscopic radical retroperitoneal lymph node dissection for low stage testis cancer. Urol Clin North Am 1999 7 : 65 77
12. Rassweiler JJ, Frede T, Lenz E, Seemann O, Alken P. Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of low-stage testis cancer. Eur Urol 2000 37 : 251 60
13. Nicolai N, Miceli R, Artusi R, Piva Luigi Pizzocaro G, Salvioni R. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. J Urol 2004 17 : 172 6
14. Beck SDW, Peterson MD, Bihrle R, Donohue JP, Foster RS. Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients. J Urol 2007 178 : 504 6
15. Heidenreich A, Albers P, Hartmann M et al. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 2003 169 : 1710 4
16. Albqami N, Janetschek G. Laparoscopic retroperitoneal lymph-node dissection in the management of clinical stage I and II testicular cancer. J Endourol 2005 19 : 683 92
17. Williams SD, Stablein DM, Einhorn LH et al. Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. NEJM 1987 317 : 1433 8
18. Pont J, Albrecht W, Postner G, Sellner F, Angel K, Holtl W. Adjuvant chemotherapy for high risk clinical stage I nonseminomatous testicular germ cell cancer. Long term results of a prospective trial. J Clin Oncol 1996 14 : 441 8